RedHill Biopharma Ltd.

NASDAQ: RDHL · Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Aug 15, 2025, 3:59 PM
1.39
1.36%
After-hours: Aug 15, 2025, 06:45 PM EDT

RedHill Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.04M 5.88M 3.71M 4.22M 6.53M 18.76M 35.74M 52.3M 66.93M 76.2M 80.26M 83.42M 85.76M 85.15M 84.48M 83.88M
Cost of Revenue
3.19M 2.82M 2.44M 2.55M 3.46M 11.54M 20.47M 28.66M 35.08M 45.81M 45.59M 47.19M 49.41M 40.72M 41.83M 45.43M
Gross Profit
4.85M 3.06M 1.26M 1.67M 3.07M 7.22M 15.28M 23.64M 31.85M 30.39M 34.67M 36.23M 36.35M 44.42M 42.65M 38.45M
Operating Income
-14.61M -17.55M -20.49M -20.67M 34.21M 30.29M 29.2M 24.45M -39.45M -50.2M -60.49M -76.22M -81.14M -80.14M -77.21M -64.82M
Interest Income
n/a n/a n/a 7.09M 28.68M 39.95M 43.14M 37.71M 16.14M 4.87M 1.7M 54.05K 86.06K 4.48M 4.51M 4.6M
Pretax Income
-8.27M -19.22M -30.17M -27.87M 23.92M 33.73M 11.57M -900K -68.28M -88.92M -74.61M -92.02M -97.74M -97.7M -94.95M -81.88M
Net Income
-8.27M -19.22M -30.17M -27.87M 23.92M 33.73M 11.57M -900K -71.67M -92.31M -78M -95.41M -97.74M -97.7M -94.95M -81.88M
Selling & General & Admin
15.52M 18.24M 20.96M 24.55M 30.98M 37.99M 45.58M 54.56M 64.03M 68.58M 78.94M 87.38M 87.99M 94.75M 91.53M 82.06M
Research & Development
1.59M 1.72M 1.86M 2.77M 3.53M 4.06M 5.08M 5.3M 7.28M 12.01M 16.22M 25.08M 29.5M 29.82M 28.32M 21.21M
Other Expenses
2.36M 644K -1.07M -4.98M -44.06M -43.53M -42.99M -39.08M n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
19.46M 20.61M 21.75M 22.34M -9.56M -1.48M 7.66M 20.77M 71.31M 80.59M 95.16M 112.45M 117.49M 124.57M 119.86M 103.27M
Interest Expense
n/a n/a n/a 1.93M 2.35M 2.35M 34.13M 36.42M 39.91M 43.61M 15.83M 15.87M 16.71M 13.01M 13.22M 12.63M
Selling & Marketing Expenses
5.95M 7.28M 8.61M 11.39M 14.76M -7.67M -3.14M 1.61M 9.06M -4.34M 4.09M 10.05M 11.38M 20.38M 18.27M 13M
Cost & Expenses
22.66M 23.43M 24.2M 24.89M -6.1M 10.06M 28.13M 49.43M 106.39M 126.41M 140.76M 159.64M 166.89M 165.29M 161.69M 148.7M
Income Tax Expense
n/a n/a n/a n/a 421K 421K 421K 421K 10K -71K -54K -39K -7K 74K 99K 192K
Shares Outstanding (Basic)
2.58M 2.58M 2.35M 2.35M 780.9K 548.13K 315.36K 194.8K 186.39K 127.67K 113.66K 105.37K 99.84K 93.58K 93.36K 85.92K
Shares Outstanding (Diluted)
2.58M 2.58M 2.35M 2.35M 780.9K 548.13K 315.36K 194.8K 186.39K 127.67K 113.66K 105.37K 99.84K 93.58K 93.36K 85.92K
EPS (Basic)
-3 -19 -42 -39 218.00 215.00 -43 -149 -600 -824 -770 -979 -1K -1.1K -1.1K -1.1K
EPS (Diluted)
-3 -19 -42 -39 218.00 215.00 -43 -149 -600 -824 -770 -979 -1K -1.1K -1.1K -1.1K
EBITDA
-11.73M -15.69M -19.51M -12.81M 41.85M 48.45M 52.28M 44.07M -21.06M -31.4M -44.65M -61.73M -63.07M -71.02M -67.84M -55.45M
EBIT
-12.25M -16.37M -20.49M -13.58M 40.83M 44.55M 46.65M 36.47M -30.34M -48.81M -62.28M -79.65M -81.14M -80.45M -77.48M -65.01M
Depreciation & Amortization
528.5K 682.5K 979.67K 1.88M 2.13M 3.95M 5.65M 6.43M 8.11M 17.36M 17.63M 18.04M 18.19M 9.52M 9.75M 9.63M